Last update 03 Feb 2026

CKD-512

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CKD 512, CKD512
Target
A2aR
Action
antagonists
Mechanism
A2aR antagonists(Adenosine A2a receptor antagonists)
Therapeutic Areas
Neoplasms
Active Indication
Metastatic Solid TumorSolid tumor
Inactive Indication-
Originator Organization
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.
Active Organization
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with CKD-512
NCT07215637
/ RecruitingPhase 1
A Multicenter, Open-label, Dose-escalation, Phase Ia/Ib Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of CKD-512 Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumor
100 Clinical Results associated with CKD-512
Login to view more data
100 Translational Medicine associated with CKD-512
Login to view more data
100 Patents (Medical) associated with CKD-512
Login to view more data
100 Deals associated with CKD-512
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Solid TumorPhase 1
South Korea
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.
16 Oct 2025
Solid tumorPhase 1
South Korea
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.
16 Oct 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free